Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
57.1M
-
Number of holders
-
207
-
Total 13F shares, excl. options
-
48.8M
-
Shares change
-
+1.21M
-
Total reported value, excl. options
-
$1.64B
-
Value change
-
+$42.7M
-
Put/Call ratio
-
0.76
-
Number of buys
-
87
-
Number of sells
-
-115
-
Price
-
$33.58
Significant Holders of Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) as of Q1 2024
250 filings reported holding HRMY - Harmony Biosciences Holdings, Inc. - Common Stock as of Q1 2024.
Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) has 207 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 48.8M shares
of 57.1M outstanding shares and own 85.47% of the company stock.
Largest 10 shareholders include Valor Management LLC (11.2M shares), BlackRock Inc. (5.92M shares), FMR LLC (5.26M shares), VANGUARD GROUP INC (3.63M shares), Vivo Capital, LLC (2.61M shares), Pacer Advisors, Inc. (2.49M shares), STATE STREET CORP (1.3M shares), venBio Partners LLC (1.04M shares), MORGAN STANLEY (885K shares), and DIMENSIONAL FUND ADVISORS LP (845K shares).
This table shows the top 207 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.